Report Detail

Medical Devices & Consumables Global Hematology Controls Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4663096
  • |
  • 19 January, 2026
  • |
  • Global
  • |
  • 96 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Hematology Controls market size was valued at US$ 403 million in 2025 and is forecast to a readjusted size of US$ 634 million by 2032 with a CAGR of 6.7% during review period.
Hematology controls are standardized materials used in laboratory testing to ensure the accuracy and reliability of hematological analyses. These controls contain known quantities of blood components such as red blood cells, white blood cells, platelets, and hemoglobin. They are used to verify the performance of hematology analyzers and reagents, providing a reference point for calibration and quality control. By comparing test results from the control materials with expected values, laboratories can identify any discrepancies, troubleshoot issues, and ensure that their equipment and techniques are functioning correctly.
The hematology controls market is primarily driven by the increasing demand for accurate and reliable diagnostic testing in the healthcare industry. As the prevalence of blood-related disorders, such as anemia, leukemia, and other hematological conditions, continues to rise globally, there is a growing need for high-quality hematology testing solutions. Additionally, advancements in automation and technology have led to the development of more efficient and precise hematology analyzers, further boosting the demand for hematology controls. These controls are essential to maintaining the quality and consistency of test results, thus enhancing the overall diagnostic accuracy and patient care.
However, the hematology controls market faces several challenges, including the high cost of advanced testing systems and the complexity of maintaining strict regulatory compliance. The development and production of hematology controls require significant investment in quality control measures and adherence to various regulatory standards, which can be costly for manufacturers. Additionally, the market's dependence on sophisticated laboratory infrastructure may limit the accessibility of hematology control products in resource-limited settings. These factors could slow down the growth of the market, particularly in emerging economies where healthcare budgets are constrained.
Global key players of Hematology Controls include Sysmex, Danaher, etc. Global top 3 companies hold a share about 70%. Asia Pacific is the largest market, with a share about 40%, followed by Europe and North America with the share about 25% and 20%. In terms of product, 3-Part is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospital, with a share over 60%.
This report is a detailed and comprehensive analysis for global Hematology Controls market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hematology Controls market size and forecasts, in consumption value ($ Million), 2021-2032
Global Hematology Controls market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Hematology Controls market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Hematology Controls market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hematology Controls
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hematology Controls market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sysmex, Danaher, Bio-Rad, Mindray, Abbott, Horiba, Boule, Diatron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Hematology Controls market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
3-Part Hematology Controls
5-Part Hematology Controls
Others
Market segment by Application
Hospital
Independent Lab
Others
Market segment by players, this report covers
Sysmex
Danaher
Bio-Rad
Mindray
Abbott
Horiba
Boule
Diatron
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hematology Controls product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hematology Controls, with revenue, gross margin, and global market share of Hematology Controls from 2021 to 2026.
Chapter 3, the Hematology Controls competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Hematology Controls market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hematology Controls.
Chapter 13, to describe Hematology Controls research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Hematology Controls by Type
    • 1.3.1 Overview: Global Hematology Controls Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Hematology Controls Consumption Value Market Share by Type in 2025
    • 1.3.3 3-Part Hematology Controls
    • 1.3.4 5-Part Hematology Controls
    • 1.3.5 Others
  • 1.4 Global Hematology Controls Market by Application
    • 1.4.1 Overview: Global Hematology Controls Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Independent Lab
    • 1.4.4 Others
  • 1.5 Global Hematology Controls Market Size & Forecast
  • 1.6 Global Hematology Controls Market Size and Forecast by Region
    • 1.6.1 Global Hematology Controls Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Hematology Controls Market Size by Region, (2021-2032)
    • 1.6.3 North America Hematology Controls Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Hematology Controls Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Hematology Controls Market Size and Prospect (2021-2032)
    • 1.6.6 South America Hematology Controls Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Hematology Controls Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Sysmex
    • 2.1.1 Sysmex Details
    • 2.1.2 Sysmex Major Business
    • 2.1.3 Sysmex Hematology Controls Product and Solutions
    • 2.1.4 Sysmex Hematology Controls Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sysmex Recent Developments and Future Plans
  • 2.2 Danaher
    • 2.2.1 Danaher Details
    • 2.2.2 Danaher Major Business
    • 2.2.3 Danaher Hematology Controls Product and Solutions
    • 2.2.4 Danaher Hematology Controls Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Danaher Recent Developments and Future Plans
  • 2.3 Bio-Rad
    • 2.3.1 Bio-Rad Details
    • 2.3.2 Bio-Rad Major Business
    • 2.3.3 Bio-Rad Hematology Controls Product and Solutions
    • 2.3.4 Bio-Rad Hematology Controls Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bio-Rad Recent Developments and Future Plans
  • 2.4 Mindray
    • 2.4.1 Mindray Details
    • 2.4.2 Mindray Major Business
    • 2.4.3 Mindray Hematology Controls Product and Solutions
    • 2.4.4 Mindray Hematology Controls Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Mindray Recent Developments and Future Plans
  • 2.5 Abbott
    • 2.5.1 Abbott Details
    • 2.5.2 Abbott Major Business
    • 2.5.3 Abbott Hematology Controls Product and Solutions
    • 2.5.4 Abbott Hematology Controls Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Abbott Recent Developments and Future Plans
  • 2.6 Horiba
    • 2.6.1 Horiba Details
    • 2.6.2 Horiba Major Business
    • 2.6.3 Horiba Hematology Controls Product and Solutions
    • 2.6.4 Horiba Hematology Controls Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Horiba Recent Developments and Future Plans
  • 2.7 Boule
    • 2.7.1 Boule Details
    • 2.7.2 Boule Major Business
    • 2.7.3 Boule Hematology Controls Product and Solutions
    • 2.7.4 Boule Hematology Controls Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Boule Recent Developments and Future Plans
  • 2.8 Diatron
    • 2.8.1 Diatron Details
    • 2.8.2 Diatron Major Business
    • 2.8.3 Diatron Hematology Controls Product and Solutions
    • 2.8.4 Diatron Hematology Controls Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Diatron Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Hematology Controls Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Hematology Controls by Company Revenue
    • 3.2.2 Top 3 Hematology Controls Players Market Share in 2025
    • 3.2.3 Top 6 Hematology Controls Players Market Share in 2025
  • 3.3 Hematology Controls Market: Overall Company Footprint Analysis
    • 3.3.1 Hematology Controls Market: Region Footprint
    • 3.3.2 Hematology Controls Market: Company Product Type Footprint
    • 3.3.3 Hematology Controls Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Hematology Controls Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Hematology Controls Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Hematology Controls Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Hematology Controls Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Hematology Controls Consumption Value by Type (2021-2032)
  • 6.2 North America Hematology Controls Market Size by Application (2021-2032)
  • 6.3 North America Hematology Controls Market Size by Country
    • 6.3.1 North America Hematology Controls Consumption Value by Country (2021-2032)
    • 6.3.2 United States Hematology Controls Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Hematology Controls Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Hematology Controls Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Hematology Controls Consumption Value by Type (2021-2032)
  • 7.2 Europe Hematology Controls Consumption Value by Application (2021-2032)
  • 7.3 Europe Hematology Controls Market Size by Country
    • 7.3.1 Europe Hematology Controls Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Hematology Controls Market Size and Forecast (2021-2032)
    • 7.3.3 France Hematology Controls Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Hematology Controls Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Hematology Controls Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Hematology Controls Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Hematology Controls Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Hematology Controls Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Hematology Controls Market Size by Region
    • 8.3.1 Asia-Pacific Hematology Controls Consumption Value by Region (2021-2032)
    • 8.3.2 China Hematology Controls Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Hematology Controls Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Hematology Controls Market Size and Forecast (2021-2032)
    • 8.3.5 India Hematology Controls Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Hematology Controls Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Hematology Controls Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Hematology Controls Consumption Value by Type (2021-2032)
  • 9.2 South America Hematology Controls Consumption Value by Application (2021-2032)
  • 9.3 South America Hematology Controls Market Size by Country
    • 9.3.1 South America Hematology Controls Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Hematology Controls Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Hematology Controls Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Hematology Controls Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Hematology Controls Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Hematology Controls Market Size by Country
    • 10.3.1 Middle East & Africa Hematology Controls Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Hematology Controls Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Hematology Controls Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Hematology Controls Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Hematology Controls Market Drivers
  • 11.2 Hematology Controls Market Restraints
  • 11.3 Hematology Controls Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Hematology Controls Industry Chain
  • 12.2 Hematology Controls Upstream Analysis
  • 12.3 Hematology Controls Midstream Analysis
  • 12.4 Hematology Controls Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Hematology Controls. Industry analysis & Market Report on Hematology Controls is a syndicated market report, published as Global Hematology Controls Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Hematology Controls market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report